Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  MAKO Surgical Corp.    MAKO

News SummaryMost relevantAll newsSector news 

MAKO Surgical Corp. : Abbott Laboratories, Boston Scientific, Medtronic and MAKO Surgical Under StockCall's Microscope

03/04/2013 | 08:05am US/Eastern

LONDON, March 4, 2013 /PRNewswire/ --

Markets remained strong throughout last week despite concerns about spending cuts. Broader market indices remained bullish and The Dow Jones closed the week at 14,089.66, up 0.25 percent while NASDAQ was up 0.30 percent to close at 3,169.74. Similarly, S&P also ended at a positive note at 1,518.20, up 0.23 percent. Our research team took a look at healthcare sector, more precisely at the Medical Appliances & Equipment industry which includes major companies like Abbott Laboratories (NYSE: ABT), Boston Scientific Corporation (NYSE:BSX), Medtronic Inc. (NYSE: MDT) and MACO Surgical Corp. (NASDAQ: MAKO). StockCall has released full comprehensive research on ABT BSX MDT and MAKO and these free technical analyses can be downloaded by signing up at


Abbott Laboratories stock closed at $33.60, 0.56 percent lower, on Friday. The stock traded in the range of $33.55 and $33.91 during the session and is currently below its 20-day moving average price of $33.62. It traded 14.60 million shares, in comparison to its usual daily volume of 12.90 million shares. Abbott Laboratories gained 2.6 percent so far this year. Its Price/Earnings ratio is 8.96. Abbott Laboratories stock is in a neutral phase and its first resistance level is at $33.69. On the downside, its first support is at $33.45. Upon breaching this level, its second support level is at $33.06. Free technical analysis on ABT available by signing up at


Despite its downward movement in the latest trading session on Friday, Boston Scientific Corp. is still up 28.62 percent for the year. It has gained 22.83 percent in the past 52 weeks. The stock closed 0.27 percent lower at $7.37 on volume of 15.93 million shares. Its average trading volume stands at 26.09 million shares. Boston Scientific shares currently face resistance at around $7.70. The stock has support at around $6.90. It is currently trading above its 50-day moving average price of $6.78, which is a bullish signal. Register today and access the free research on BSX at


Medtronic Inc. traded in the range of $44.51 and $45.31 during its previous trading session on Friday. It opened at $44.80 and closed at $45.23, up 0.60 percent. The stock is currently in a neutral mode and it has a first resistance level at $46.25. Upon breaching this level, Medtronic may go as high as $47.33. The stock traded 4.37 million shares and is currently above its 20-day moving average price. Its first support level is at $44.76, while its second support level stands at $43.88. So far in 2013, the stock is up 10.26 percent, while it gained more than 19 percent in the past 52 weeks. The free report on MDT can be downloaded by signing up now at


Despite the upward movement shown by broad market indices, MACO Surgical's stock finished 0.31 percent lower at $12.75, with volume down from daily average of 1.34 million to 1.25 million shares. MACO Surgical Corp.'s stock lost 0.78 percent value so far in this year. However, the stock currently shows a neutral trend which is further confirmed by the stock's MACD chart. The company's shares have first support level at $12.16. Upon breaching this level, the stock may tumble down to $10.89. In the coming trading sessions, the stock is likely to go as high as $13.28. Its second resistance level is at $13.84. Free report on MAKO can be accessed by registering at


About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at


SOURCE StockCall.com

React to this article
Latest news on MAKO SURGICAL CORP.
2013 MAKO SURGICAL CORP. : Stryker Completes Acquisition of MAKO Surgical Corp.
2013 MAKO SURGICAL CORP. : Stockholders Approve Merger With Stryker Corporation
2013 MAKO SURGICAL CORP. : FDA Approval, FY 2013 & Q4 FY 2013 Outlook, and Stock Pric..
2013DJFIDELITY MANAGEMENT & RESEARCH CO. 3 : Largest Eliminations
2013DJAQR CAPITAL MANAGEMENT 3Q 13F : Largest Purchases -2-
2013DJAQR CAPITAL MANAGEMENT 3Q 13F : Largest Purchases
2013DJCR INTRINSIC INVESTORS 3Q 13F : Largest Eliminations
2013DJGAMCO ASSET MANAGEMENT INC. 3Q 13F : Largest Purchases